Financial News
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
More in Financial News
-
Republicans could still win the House in the 2026 midterm election: Scalise
The election is high stakes and will effectively determine whether Trump enters ’27 as...
-
GDP rose at 2% annual rate in first quarter as U.S. economy rebounds
The U.S. economy expanded at an annual rate of 2% in the first three...
-
Treasury Department announces new Series I bond rate of 4.26% for the next six months
The U.S. Department of the Treasury has announced new Series I bond rates through...
-
How to pay off $15,000 in debt by the end of 2026
Debt balances have been climbing rapidly over the last year, and so have the...


